Similarly, a large cohort study evaluating immunotherapy response in triple-negative breast cancer using spatial IMC analysis showed a similar phenomenon of 16 TME cell phenotypes associated with response most notably CD8+TCF1+T cells being the strongest predictor of overall response79. Here, CD8A is linked to triple-negative breast carcinoma.